Showing 1 - 9 results of 9 for search 'A. V. Taganov', query time: 0.03s
Refine Results
-
1
Atopic dermatitis, modern strategy in the therapy by V. A. Revyakina, A. V. Taganov, E. D. Kuvshinova, I. A. Larkova, V. A. Mukhortykh
Published 2021-06-01Get full text
Article -
2
Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia) by T. N. Komarov, N. S. Bagaeva, K. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, V. S. Shcherbakova, K. Ya. Zaslavskaya, P. A. Bely, A. V. Taganov, I. E. Shohin
Published 2024-03-01Get full text
Article -
3
Comparative analysis of pharmacokinetic parameters, bioequivalence, safety, tolerability and immunogenicity of semaglutide-based drug for the treatment of obesity by A. S. Ametov, P. A. Bely, K. Y. Zaslavskaya, E. A. Rogozhina, V. S. Shcherbakova, Y. G. Kazaishvili, A. V. Taganov, T. G. Bodrova, E. S. Mishchenko, K. N. Koryanova, L. I. Shcherbakova
Published 2025-03-01Get full text
Article -
4
Analysis of cytokine response characteristics and immunopathogenetic effects of double-stranded sodium salt RNA-based drug for postexposure prophylaxis against novel coronavirus in... by O. A. Radaeva, L. A. Balykova, K. Ya. Zaslavskaya, Yu. A. Kostina, N. A. Pyataev, N. M. Selezneva, A. V. Klimova, I. Yu. Chegodaeva, K. N. Koryanova, A. V. Taganov, P. A. Bely
Published 2023-08-01Get full text
Article -
5
STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD by O. A. Radaeva, L. A. Balykova, K. Ya. Zaslavskaya, A. V. Taganov, P. A. Bely, Yu. A. Kostina, E. V. Negodnova, S. V. Mashnina, D. D. Bessheinov, M. S. Iskandyarova, V. V. Eremeev, N. M. Chumakov
Published 2022-05-01Get full text
Article -
6
MODERN DIRECTED ANTIVIRAL COVID-19 THERAPY: RESULTS OF MULTICENTER CLINICAL EFFECTIVENESS AND SAFETY STUDY OF FIXED NIRMATRELVIR+RITONAVIR COMBINATION by L. A. Balykova, N. M. Selezneva, E. I. Gorshenina, O. I. Shepeleva, N. V. Kirichenko, E. N. Simakina, K. B. Kolontarev, D. Yu. Pushkar, D. N. Zemskov, K. Ya. Zaslavskaya, S. M. Noskov, A. V. Taganov, P. A. Bely
Published 2022-10-01Get full text
Article -
7
The efficacy of liraglutide-based drugs on the model of induced metabolic syndrome in experimental animals by A. A. Andreev-Andrievsky, M. A. Mashkin, M. Vannous, O. V. Fadeeva, Yu. G. Kazaishvili, D. V. Kurkin, K. Ya. Zaslavskaya, P. A. Bely, A. V. Taganov, E. A. Rogozhina, K. N. Koryanova, E. S. Mishchenko, T. G. Bodrova, V. S. Shcherbakova
Published 2025-08-01Get full text
Article -
8
EFFECTIVENESS AND SAFETY OF FAVIPIRAVIR INFUSION IN PATIENTS HOSPITALIZED WITH COVID-19 by L. A. Balykova, K. Ya. Zaslavskaya, V. F. Pavelkina, N. A. Pyataev, N. M. Selezneva, N. V. Kirichenko, A. Yu. Ivanova, G. V. Rodoman, K. B. Kolontarev, K. S. Skrupsky, E. N. Simakina, O. A. Mubarakshina, A. V. Taganov, D. Yu. Pushkar
Published 2022-03-01Get full text
Article -
9
Post-exposure prophylaxis of COVID-19: results of double-blind, placebo-controlled, multicenter clinical study evaluation of efficacy and safety of double-stranded sodium salt RNA... by L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, A. V. Taganov, P. A. Bely, K. A. Zakharov, V. V. Popova, T. I. Chudinovskikh, S. V. Teplykh, I. V. Balaban, R. S. Kozlov, N. V. Kirichenko, E. N. Simakina, K. N. Koryanova, D. Yu. Pushkar
Published 2023-05-01Get full text
Article